Affective and anxiety disorders: prevalence, treatment and antidepressant medication use

References

• Mathers CD, Vos ET, Stevenson CE, Begg SJ. The burden of disease and injury in Australia. Bull World Health Organ 2001; 79:1076–1084.
   PubMed Web of Science ®Google Scholar
• Begg SJ, Vos T, Barker B, Stanley L, Lopez AD. Burden of disease and injury in Australia in the new millennium: measuring health loss from diseases, injuries and risk factors. Med J Aust 2008; 188:36–40.
   PubMed Web of Science ®Google Scholar
• Henderson S, Andrews G, Hall W. Australia’s mental health: an overview of the general population survey. Aust N Z J Psychiatry 2000; 34:197–205.
   PubMed Web of Science ®Google Scholar
• Parslow RA, Jorm AF. Who uses mental health services in Australia? An analysis of data from the National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2000; 34:997–1008.
   PubMed Web of Science ®Google Scholar
• Burgess PM, Pirkis JE, Slade TN, Johnston AK, Meadows GN, Gunn JM. Service use for mental health problems: findings from the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2009; 43:615–623.
   PubMed Web of Science ®Google Scholar
• Jorm AF, Christensen H, Griffiths KM. Changes in depression awareness and attitudes in Australia: the impact of beyondblue: the national depression initiative. Aust N Z J Psychiatry 2006; 40:42–46.
   PubMed Web of Science ®Google Scholar
• Hickie IB, Pirkis JE, Blashki GA, Groom GL, Davenport TA. General practitioners’ response to depression and anxiety in the Australian community: a preliminary analysis. Med J Aust 2004; 181:S15–20.
   PubMed Web of Science ®Google Scholar
• Morley B, Pirkis J, Sanderson K . Better outcomes in mental health care: impact of different models of psychological service provision on patient outcomes. Aust N Z J Psychiatry 2007; 41:142–149.
   PubMed Web of Science ®Google Scholar
• Pirkis J, Stokes D, Morley B . Impacts of Australia’s Better Outcomes in Mental Health Care Program for psychologists. Aust Psychologist 2006; 41:152–159.
   Web of Science ®Google Scholar
• Whiteford H, Doessel D, Sheridan JS. Uptake of Medical Benefits Schedule items by psychologists and other mental health practitioners. Clin Psychologist 2008; 12:50–56.
   Google Scholar
• Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008; 5:e45.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Furukawa TA, Salanti G . Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009; 373:746–758.
   PubMed Web of Science ®Google Scholar
• Hall WD, Mant A, Mitchell PB, Rendle VA, Hickie IB, McManus P. Association between antidepressant prescribing and suicide in Australia, 1991–2000: trend analysis. BMJ 2003; 326:1008–11.
   PubMed Web of Science ®Google Scholar
• McManus P, Mant A, Mitchell PB, Montgomery WS, Marley J, Auland ME. Recent trends in the use of antidepressant drugs in Australia, 1990–1998. Med J Aust 2000; 173:458–461.
   PubMed Web of Science ®Google Scholar
• Smith AJ, Sketris I, Cooke C, Gardner D, Kisely S, Tett SE. A comparison of antidepressant use in Nova Scotia, Canada and Australia. Pharmacoepidemiol Drug Saf 2008; 17:697–706.
   PubMed Web of Science ®Google Scholar
• Department of Health and Ageing. Top 10 drugs. Aust Prescriber 2008; 31:164.
   Google Scholar
• Kessler RC, Ustun TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004; 13:93–121.
   PubMed Web of Science ®Google Scholar
• Slade T, Johnson A, Oakley-Browne M, Andrews G, Whiteford H. 2007 National Survey of Mental Health and Wellbeing: methods and key findings. Aust N Z J Psychiatry 2009; 43:594–605.
   PubMed Web of Science ®Google Scholar
• Hollingworth S, Siskind D. Anxiolytic, hypnotic and sedative medication use i Australia. Pharmacoepidemiol Drug Safety 2010; 19:280–288.
   PubMed Web of Science ®Google Scholar
• Australian Bureau of Statistics. Technical manual: National Survey of Mental Health and Wellbeing, confidentialised unit record files, Cat. No. 4329.0. Canberra: Australian Bureau of Statistics, 2007.
   Google Scholar
• World Health Organization. WHO Collaborating Centre for Drug Statistics Methodology. Oslo: Norwegian Institute of Public Health, 2008.
   Google Scholar
• Australian Bureau of Statistics. Population by age and sex, Australian States and Territories, Cat. No. 3201.0. Canberra: Australian Bureau of Statistics, 2007.
   Google Scholar
• Australian Government Department of Health and Ageing. Australian statistics on medicines 2006. Canberra: Department of Health and Ageing, 2008.
   Google Scholar
• Jorm AF, Christensen H, Griffiths KM. The impact of beyondblue: the national depression initiative on the Australian public’s recognition of depression and beliefs about treatments. Aust N Z J Psychiatry 2005; 39:248–254.
   PubMed Web of Science ®Google Scholar
• Jorm AF, Christensen H, Griffiths KM. The public’s ability to recognize mental disorders and their beliefs about treatment: changes in Australia over 8 years. Aust N Z J Psychiatry 2006; 40:36–41.
   PubMed Web of Science ®Google Scholar
• Cresswell KM, Fernando B, McKinstry B, Sheikh A. Adverse drug events in the elderly. Br Med Bull 2007; 83:259–274.
   PubMed Web of Science ®Google Scholar
• Friedman AL, Geoghegan SR, Sowers NM, Kulkarni S, Formica RN Jr. Medication errors in the outpatient setting: classification and root cause analysis. Arch Surg 2007; 142:278–283; discussion 284.
   PubMed Web of Science ®Google Scholar
• Mant A, Rendle VA, Hall WD . Making new choices about antidepressants in Australia: the long view 1975–2002. Med J Aust 2004; 181:S21–24.
   PubMed Web of Science ®Google Scholar
• McManus P, Mant A, Mitchell P, Britt H, Dudley J. Use of antidepressants by general practitioners and psychiatrists in Australia. Aust N Z J Psychiatry 2003; 37:184–189.
   PubMed Web of Science ®Google Scholar
• Page AN, Swannell S, Martin G, Hollingworth S, Hickie IB, Hall WD. Sociodemographic correlates of antidepressant utilisation in Australia. Med J Aust 2009; 190:479–483.
   PubMed Web of Science ®Google Scholar
• Smith AJ, Sketris I, Cooke C, Gardner D, Kisely S, Tett SE. A comparison of benzodiazepine and related drug use in Nova Scotia and Australia. Can J Psychiatry 2008; 53:545–552.
   PubMed Web of Science ®Google Scholar
• Carlsten A, Waern M, Ekedahl A, Ranstam J. Antidepressant medication and suicide in Sweden. Pharmacoepidemiol Drug Saf 2001; 10:525–530.
   PubMed Web of Science ®Google Scholar
• Paulose-Ram R, Safran MA, Jonas BS, Gu Q, Orwig D. Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiol Drug Saf 2007; 16:560–570.
   PubMed Web of Science ®Google Scholar
• Trifiro G, Barbui C, Spina E . Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003–2004. Pharmacoepidemiol Drug Saf 2007; 16:552–559.
   PubMed Web of Science ®Google Scholar
• Ufer M, Meyer SA, Junge O . Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis. Pharmacoepidemiol Drug Saf 2007; 16:1153–1160.
   PubMed Web of Science ®Google Scholar
• Craig D, Passmore AP, Fullerton KJ . Factors influencing prescription of CNS medications in different elderly populations. Pharmacoepidemiol Drug Saf 2003; 12:383–387.
   Google Scholar
• Lawrenson RA, Tyrer F, Newson RB, Farmer RD. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J Affect Disord 2000; 59:149–157.
   PubMed Web of Science ®Google Scholar
• Wei L, Chen R, MacDonald TM. Channelling of SSRIs and SNRIs use in the Tayside population, Scotland. Pharmacoepidemiol Drug Saf 2007; 16:859–866.
   Google Scholar
• Munoz-Arroyo R, Sutton M, Morrison J. Exploring potential explanations for the increase in antidepressant prescribing in Scotland using secondary analyses of routine data. Br J Gen Pract 2006; 56:423–428.
   PubMedGoogle Scholar
• Patten SB, Esposito E, Carter B. Reasons for antidepressant prescriptions in Canada. Pharmacoepidemiol Drug Saf 2007; 16:746–752.
   PubMed Web of Science ®Google Scholar